CAUSES OF ADULT SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA
Authors:
- Valerio De StefanoVSValerio De Stefano
- Angela CiminelloACAngela Ciminello
- Laura BettiLBLaura Betti
- Elena RossiERElena Rossi
Open Access
- 3 January 2011
- journal article
- Published by Hematology Section, Dept. of Radiological Science and Hematology, Catholic University, Rome, Italy in Mediterranean Journal of Hematology and Infectious Diseases
- Vol. 3 (1) , e2011063
Abstract
The term splanchnic vein thrombosis encompasses Budd-Chiari syndrome (BCS), extrahepatic portal vein obstruction (EHPVO), and mesenteric vein thrombosis. Risk factors can be local or systemic. A local precipitating factor is rare in BCS, while it is common in patients with portal vein thrombosis. Chronic myeloproliferative neoplasms (MPN) are the leading systemic cause of splanchnic vein thrombosis, and are diagnosed in half BCS patients and one-third of EHPVO patients; the molecular marker JAK2 V617F is detectable in a large majority of patients with overt MPN and up to 40% of patients without overt MPN. Inherited thrombophilia is present in at least one-third of patients, and the factor V Leiden or the prothrombin G20210A mutations are the most common mutations found in BCS or EHPVO patients, respectively. Multiple factors are present in approximately one-third of patients with BCS and two- thirds of patients with portal vein thrombosis. In a few patient series from the Southern Mediterranean area the high prevalence of MPN and thrombophilia as underlying cause of BCS is confirmed, although the data should be considered preliminary. Peculiar risk factors present in the area are Behcet’s disease and hydatidosis; moreover, the presence of membraneous webs, typically found in Asian patients, can be found in a significant portion of cases.Keywords
This publication has 41 references indexed in Scilit:
- Etiology, Management, and Outcome of the Budd-Chiari SyndromeAnnals of Internal Medicine, 2009
- Budd‐Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival – an 18‐year experienceLiver International, 2009
- Is JAK2 V617F mutation more than a diagnostic index?Leukemia Research, 2009
- Budd Chiari syndrome: experience at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.2003
- Mesenteric Venous ThrombosisNew England Journal of Medicine, 2001
- Recent Portal or Mesenteric Venous Thrombosis: Increased Recognition and Frequent Recanalization on Anticoagulant TherapyHepatology, 2000
- Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndromeJournal of Hepatology, 2000
- Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shuntingHepatology, 1999
- Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver.1991
- VENO-OCCLUSIVE DISEASE AND PRIMARY HEPATIC VEIN-THROMBOSIS IN ISRAELI ARABS1981